Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-A? APP mutation.
Ontology highlight
ABSTRACT: Pathogenic amyloid-? peptide precursor (APP) mutations clustered around position 693 of APP-position 22 of the A? sequence--are commonly associated with congophilic amyloid angiopathy (CAA) and intracerebral hemorrhages. In contrast, the Osaka (E693?) intra-A? APP mutation shows a recessive pattern of inheritance that leads to AD-like dementia despite low brain amyloid on in vivo positron emission tomography imaging. Here, we investigated the effects of the Osaka APP mutation on A? accumulation and deposition in vivo using a newly generated APP transgenic mouse model (E22?A?) expressing the Osaka mutation together with the Swedish (K670N/M671L) double mutation. E22?A? mice exhibited reduced ?-processing of APP and early accumulation of intraneuronal fibrillar A? oligomers associated with cognitive deficits. In line with our in vitro findings that recombinant E22?-mutated A? peptides form amyloid fibrils, aged E22?A? mice showed extracellular CAA deposits in leptomeningeal cerebellar and cortical vessels. In vitro results from thioflavin T aggregation assays with recombinant A? peptides revealed a yet unknown antiamyloidogenic property of the E693? mutation in the heterozygous state and an inhibitory effect of E22? A?42 on E22? A?40 fibrillogenesis. Moreover, E22? A?42 showed a unique aggregation kinetics lacking exponential fibril growth and poor seeding effects on wild-type A? aggregation. These results provide a possible explanation for the recessive trait of inheritance of the Osaka APP mutation and the apparent lack of amyloid deposition in E693? mutation carriers.
SUBMITTER: Kulic L
PROVIDER: S-EPMC3565767 | biostudies-literature | 2012 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA